Ro, a New York, NY-based patient-driven telehealth company, completed a $200m Series C funding round.
The round was led by existing investor General Catalyst, with participation from existing investors FirstMark Capital, Torch, SignalFire, TQ Ventures, Initialized Capital, 3L, and BoxGroup, as well as first time investor The Chernin Group. With this new round, Ro has raised a total of $376m since its founding in 2017.
Led by Zachariah Reitano, Co-Founder & CEO, Ro builds technology to power three digital health clinics — Roman for men’s health, Rory for women’s health, and Zero for fighting smoking cessation — as well as Ro Pharmacy, an online pharmacy where every generic medication is $5 per month. The company’s nationwide network of physicians and pharmacies provides a personalized healthcare experience from online treatment to the delivery of medication and ongoing care.